Facebook Recommended on Weakness and 4 Stock Analyses to Track

Sequenom Inc. (NASDAQ:SQNM): Oppenheimer said Wellpoint posted a positive review for cell-free fetal DNA based prenatal screening for Aneuploidy and indicated Sequenom Inc.’s MaterniT21 test will be picked up. The analyst said this is the first significant achievement for Sequenom towards their goal of achieving reimbursement from national players and reiterates their Outperform rating.

Akamai Technologies Inc. (NASDAQ:AKAM): J.PMorgan said Akamai Technologies Inc. is benefiting from the recent release of Google maps onto iOS which is bringing an increase of traffic into the fourth quarter. Shares are Neutral rated.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Facebook, Inc. (NASDAQ:FB): Topeka believes there is confusion regarding the AllthingsDigital article and noted they are referencing the Mobile Add Network and not the Ad Exchange, their real time bidding platform. The firm recommends buying Facebook on weakness due to the confusion.

VeriFone Systems, Inc (NYSE:PAY): Argus anaticipates that VeriFone Systems, Inc.’s free cash flow will nearly double in the fiscal year 2013 and they to be pleased with the company’s long-term growth outlook.  They view the stock’s valuation as attractive and maintain a Buy rating on the stock.

Express Scripts Inc. (NASDAQ:ESRX): Credit Suisse said weakness in Express Scripts Inc. related to EHB Formulary Designs is unwarranted on old and misunderstood news. Shares are Outperform rated with a $65 price target.

Don’t Miss: Here’s Why Research in Motion Actually Has a Fighting Chance.